Contact Information (Address) |
Department of Cardiovascular Medicine and Nephrology, Dokkyo Medical University Nikko Medical Center 145 Moritomo, Nikko, Tochigi,
JAPAN 321-1298 |
Contact Information (Email) |
y-maejima@dokkyomed.ac.jp
Yasuhiro Maejima, MD,PhD, Professor and Chairman of the Department of Cardiovascular Medicine and Nephrology at Dokkyo Medical University Nikko Medical Center. |
Ideal Candidate Position |
Post doctor researcher, students who wish to go to graduate school |
Required Skill and Ideal Candidate Profile |
Proficiency in English communication sufficient for living abroad is essential.
Experience with ELISA, RT-PCR, cell culture, Western blotting, and immunostaining is preferred but not required. |
Treatment from facilities |
Grant no,
Dormitory yes (free for Post doctor researcher and post-graduate students from foreign countries) |
Others / Comments |
Nikko City, located in Tochigi Prefecture, Japan, is distinguished by its rich natural environment – designated as a national park – and by its numerous historically and culturally significant temples and shrines, including Nikko Toshogu Shrine, an UNESCO World Heritage Site. This prominent destination attracts approximately 10 million visitors annually from both domestic and international origins.
Situated in this culturally and environmentally significant region, Dokkyo Medical University Nikko Medical Center functions as a central institution for advanced healthcare delivery. It plays a pivotal role in maintaining the health and safety of both the local population and the considerable number of visiting tourists.
In parallel with its clinical mission, the medical center is actively engaged in both molecular, physiological and clinical research, with a particular emphasis on cardiovascular medicine. Our basic research program is centered on elucidating the molecular mechanisms regulating autophagy in cardiomyocytes, with the ultimate goal of advancing our understanding of cellular homeostasis and identifying novel therapeutic targets for the prevention of heart failure.
A second major research initiative is focused on the scientific basis of cardiovascular rehabilitation – a therapeutic modality with considerable clinical potential for patients with cardiovascular and end-stage renal diseases. Despite its growing clinical application, the mechanistic underpinnings of rehabilitation remain poorly defined. We are therefore pursuing investigations aimed at elucidating its biological mechanisms and optimizing its efficacy.
Furthermore, we conduct epidemiological and pathophysiological research into rare and refractory cardiovascular disorders, including large vessel vasculitis, cardiac amyloidosis, cardiac sarcoidosis, idiopathic cardiomyopathies, and cardiovascular toxicities associated with cancer therapies.
We extend a warm invitation to early-career researchers worldwide who are motivated to contribute to high-impact cardiovascular science within a research environment that is both intellectually stimulating and situated in one of the most historically and naturally distinguished regions in Japan.
|